InChI=1S/C62H111N11O14/c1-24-42-57(82)67(17)33-47(75)68(18)43(29-34(2)3)54(79)66-48(37(8)9)60(85)69(19)44(30-35(4)5)53(78)63-40(13)52(77)64-41(14)56(81)71(21)46(32-62(15,16)87)59(84)70(20)45(31-36(6)7)58(83)72(22)49(38(10)11)61(86)73(23)50(55(80)65-42)51(76)39(12)27-25-26-28-74/h25-26,34-46,48-51,74,76,87H,24,27-33H2,1-23H3,(H,63,78)(H,64,77)(H,65,80)(H,66,79)/b26-25+/t39-,40+,41-,42+,43+,44+,45+,46+,48+,49+,50+,51-/m1/s1 |
OQLOXFAEYPRXJG-DQCBHWIGSA-N |
[C@H]1(N(C([C@@H](N(C([C@@H](N(C)C([C@@H](N(C([C@H](NC([C@@H](NC([C@@H](N(C([C@@H](NC([C@@H](N(C)C(CN(C([C@@H](NC1=O)CC)=O)C)=O)CC(C)C)=O)C(C)C)=O)C)CC(C)C)=O)C)=O)C)=O)C)CC(O)(C)C)=O)CC(C)C)=O)C)C(C)C)=O)C)[C@@H]([C@@H](C/C=C/CO)C)O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
drug metabolite
|
|
View more via ChEBI Ontology
(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-[(1R,2R,4E)-1,6-dihydroxy-2-methylhex-4-en-1-yl]-30-ethyl-9-(2-hydroxy-2-methylpropyl)-6,18,24-triisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone
|
AM19
|
ChEBI
|
cyclosporin A metabolite AM19
|
ChEBI
|
cyclosporin metabolite AM19
Note: (2018-02-15) The letter A before the letter M indicates that the compound is a metabolite of cyclosporin A; G would mean it was a metabolite of cyclosporin G, etc. (see Transplant. Proc., 1990, 22/3, 1357). |
|
ChEBI
|
cyclosporin metabolite M8
|
ChEBI
|
M8
|
ChEBI
|
1362930
|
PubMed citation
|
Europe PMC
|
1895678
|
PubMed citation
|
Europe PMC
|
1943052
|
PubMed citation
|
Europe PMC
|
1971578
|
PubMed citation
|
Europe PMC
|
2642763
|
PubMed citation
|
Europe PMC
|
2944258
|
PubMed citation
|
Europe PMC
|
2948307
|
PubMed citation
|
Europe PMC
|
3311467
|
PubMed citation
|
Europe PMC
|
3538573
|
PubMed citation
|
Europe PMC
|
|